Maagkanker

Bronnen en Literatuur

Bronnen

• CBS Doodsoorzakenstatistiek. Gegevens omtrent de doodsoorzaken van alle in Nederlandse bevolkingsregisters ingeschreven overledenen.
• CBS StatLine. De elektronische databank van het CBS. Bevat statistische informatie over vele maatschappelijke en economische onderwerpen in de vorm van tabellen en grafieken.
• EPIC. European Prospective Investigation into Cancer and Nutrition.
• EUCAN. European network of Cancer Registries (IARC)
• EUROCARE. EUROCARE (IARC)
• Eurostat. Statistische Database van de Europese Unie
• IKA. Kankerregistratie IKA-regio (Noord-Holland en Flevoland)
• IKZ. Kankerregistratie IKZ-regio (Noord-Brabant en Noord-Limburg).
• LMR. Landelijke Medische Registratie (Dutch Hospital Data).
• NKR. Nederlandse Kanker Registratie

Literatuur

• Bagnardi V, Blangiardo M, Vecchia CL, Corrao G.A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001; 85: 1700-5.
• Bonenkamp JJ, Hermans J, Sasako M, Velde CJ van de.Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340: 908-14.
• Botterweck AAM, Schouten LJ, Volovics A, Dorant E, Van den Brandt PA.Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654.
• Coebergh JWW, Heijden LH van der, Janssen-Heijnen MLG (eds.). Cancer incidence and survival in the Southeast of the Netherlands 1955-1994. Eindhoven: Integraal Kankercentrum Zuid,1995.
• Correa P.Meeting Report. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prevention 1996; 5: 477-481.
• Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, et al.Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer, 2001; 93: 148-52.
• El Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology,2003; 124(5): 1193-1201.
• Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst,2003; 95(18): 1404-1413.
• Faivre J, Forman D, Esteve J, Gatta G.Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE working group. Eur J Cancer 1998; 34: 2167-75.
• Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst,2002; 94(22): 1680-1687.
• Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol, 1997; 8(2): 163-168.
• Gonzalez CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer,2006; 118(10): 2559-2566.
• Gonzalez CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer,2003; 107(4): 629-634.
• Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392(6674): 402-405. Nature,1998; 392(6674): 402-405.
• Hartgrink HH, Putter H, Klein KE, Bonenkamp JJ, Velde CJ van de. Value of palliative resection in gastric cancer. Br J Surg,2002; 89(11): 1438-1443.
• Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M.Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-7.
• IKZ, Integraal Kankercentrum Zuid.Van meten naar weten; 50 jaar kankerregistratie. Eindhoven: IKZ, 2005.
• La Vecchia C, Negri E, Levi F, Decarli A, Boyle P.Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998; 34(1): 118-41.
• Lanschot JJB van, Gouma DJ, Tytgat GNJ, et al.Gastric Cancer. In Integrated Medical and Surgical Gastro-enterology. Houten: Bohn, Stafleu, van Loghum, 2004.
• Lauren P.The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
• Levi F, Lucchini F, Gonzalez JR, Fernandez E, Negri E, La Vecchia C.Monitoring falls in gastric cancer mortality in Europe. Annals of Oncology, 2004a; 15: 338-45.
• Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer,2005; 53(1): 1-10.
• Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol,2005a; 90(3): 114-133.
• Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345(10): 725-30.
• Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer,2006; 42(6): 708-716.
• McLaughlin JK, Hrubec Z, Blot WJ, Fraumein JF.Smoking and cancer mortality among US veterans: a 26-year follow-up. Int J Cancer 1995; 60: 190-193.
• Meyerhardt JA, Fuchs CS.Chemotherapy options for gastric cancer. Semin Radiat Oncol 2002; 12: 176-86.
• Minsky BD.The role of radiation therapy in gastric cancer. Semin Oncol 1996; 23: 390-6.
• Murakami K, Kodama M, Fujioka T. Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis. World J Gastroenterol,2006; 12(17): 2713-2720.
• Nyren O, Blot WJ. Helicobacter pylori Infection: Mainly Foe but Also Friend? J Natl Cancer Inst,2006; 98(20): 1432-1434.
• Oberhuber G, Stolte M. Gastric polyps: an update of their pathology and biological significance. 2000; 437(6): 581-590. Virchows Arch,2000; 437(6): 581-590.
• Ohkuwa M, Ohtsu A, Boku N, Yoshida S, Miyata Y, Shirao K.Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials. Gastric Cancer, 2000; 3: 145-50.
• Peek RM, JR, Moss SF, Tham KT, Perez-Perez GI, Wang S, Miller GG, et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst,1997; 89(12): 863-868.
• Poos MJJC, Smit JM, Groen J, Kommer GJ, Slobbe LCJ. Kosten van ziekten in Nederland 2005. RIVM-rapport nr. 270751019. Bilthoven: RIVM,2008.
• Reed PI. Helicobacter pylori and gastric cancer. Eur J Cancer Prev,1996b; 5(Suppl 2): 49-55.
• Rosch T. Endosonographic staging of gastric cancer: a review of literature results. 1995; 5(3): 549-557. Gastrointest Endosc Clin N Am,1995; 5(3): 549-557.
• Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al.EUROCARE-3: survival of cancer patients diagnosed 1990-94. Results and commentary. Ann Oncol, 2003a; 14(Suppl 5): v61-118.
• Schlemper RJ, Itabashi M, Kato Y.Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997; 349: 1725-29.
• Smith MG, Hold GL, Tahara E, El Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol,2006a; 12(19): 2979-2990.
• Thompson GB, Heerden JA van, Sarr MG.Adenocarcinoma of the stomach: are we making progress? Lancet 1993; 342: 713-8.
• Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer,1997; 72(4): 565-573.
• Tytgat GNJ, Groote J de, Tongeren JHM van, Vantrappen G (red.).Leerboek maag, darm- en leverziekten. Utrecht: Bohn, Scheltema & Holkema, 1985.
• UICC, International Union Against Cancer.TNM classification of malignant tumours, 6th edition, 2002. Berlijn: Springer-Verlag, 2002.
• Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell,2004; 5(2): 121-125.
• Valverde CM, Macarulla T, Casado E, Ramos FJ, Martinelli E, Tabernero J. Novel targets in gastric and esophageal cancer. Crit Rev Oncol Hematol,2006; 59(2): 128-38.
• Verdecchia A, Corazziari I, Gatta G, Lisi D, Faivre J, Forman D.Explaining gastric cancer survival differences among European countries. Int J Cancer, 2004; 109(5): 737-41.
• Voedingscentrum.Zo eet Nederland. Resultaten van de voedselconsumptiepeiling 1997-1998. Den Haag: Voedingscentrum, 1998a.
• Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R.Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-592.
• WCRF & AICR, World Cancer Research Fund & American Institute for Cancer Research.Food, nutrition, and the prevention of cancer: a global perspective. Washington DC: AICR, 1997.
• Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK.Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997; 15: 261-7.
• Willett CG.Results of radiation therapy in gastric cancer. Semin Radiat Oncol 2002; 12: 170-5.
• Zwaveling A, Bosman FT, Schaberg A. Velde CJH van de, Wagener DJTh. (eds.).Oncologie. Houten: Bohn Stafleu Van Loghum, 1991.